Benzonatate
NDC 42708-171, Benzonatate, capsule, from QPharma Inc.
- Product NDC
- 42708-171
- Status
- Listed
- Labeler
- QPharma Inc
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206948
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42708-171 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BENZONATATE200 mg/1
Pharmacologic classes
Decreased Tracheobronchial Stretch Receptor Activity [PE]; Non-narcotic Antitussive [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42708-171-21 | 42708017121 | 21 CAPSULE in 1 BOTTLE, PLASTIC (42708-171-21) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fbd07fb0-c49c-a838-e053-6394a90a5f0e
Use it
Look up 42708-171 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42708-171 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42708-171. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.